Osteoporosis and Dental Implant Outcomes

Osteoporosis is a skeletal condition in which mineral is lost from bones, resulting in an increased risk of fracture. Bone resorption and bone deposition occur physiologically throughout life.

Osteoporosis results from resorption outpacing deposition, and changes in structural integrity make fracture more likely. Patients with osteoporosis have a bone mass density (BMD) at least 2.5 standard deviations below the benchmark, which is the BMD of a healthy 30-year-old of the same gender.1Pitts NB, Zero DT, Marsh PD, Ekstrand K, Weintraub JA, Ramos-Gomez F, Tagami J, Twetman S, Tsakos G, Ismail A. Dental caries. Nat Rev Dis Primers 2017;25(3):17030.,2JD. The caries balance: the basis for caries management by risk assessment. Oral Health Prev Dent 2004;2(Suppl 1):259-64. This is represented as a T-score of ≤-2.5 versus the benchmark. Osteopenia is an intermediate condition between normal bone density and osteoporosis, and is defined as a T-score between ≤-1 to >-2.5.2Featherstone JD. The caries balance: the basis for caries management by risk assessment. Oral Health Prev Dent 2004;2(Suppl 1):259-64. As a result of its potential impact in the maxilla and mandible, the effect of osteoporosis on the placement and long-term survival of dental implants has been examined.3Shuler CF. Inherited risks for susceptibility to dental caries. J Dent Educ 2001;65(10):1038-45. Given the low BMD seen with osteoporosis, there has been concern that the rate of bone-to-implant contact, bone support and implant survival may be impaired in patients with osteoporosis.4Opal S, Garg S, Jain J, Walia I. Genetic factors affecting dental caries risk. Aust Dent J 2015;60:2-11.,5Bretz WA, Corby PM, Melo MR, Coelho MQ, Costa SM, Robinson M, Schork NJ, Drewnowski A, Hart TC. Heritability estimates for dental caries and sucrose sweetness preference. Arch Oral Biol 2006;51(12):1156-60.,6Nibali L, Di Iorio A, Tu YK, Vieira A. Host genetics role in the pathogenesis of periodontal disease and caries. J Clin Periodontol 2017;44:S18:52-78.,7Lips A, Antunes LS, Pintor AVB, dos Santos DAB, Bachinski R, Küchler EC, Alves GG. Salivary protein polymorphisms and risk of dental caries: a systematic review. Braz Oral Res 2017;31:e41.

Implant survival rates and marginal bone loss

A recent systematic review and meta-analysis of 15 studies included almost 9,000 patients with close to 30,000 implants placed in individuals with and without osteoporosis.8Wang X, Shaffer JR, Weyant RJ, Cuenco KT, DeSensi RS, Crout R, McNeil DW, Marazita ML. Genes and their effects on dental caries may differ between primary and permanent dentitions. Caries Res 2010;44:277-84. The data indicated no statistically significant differences in implant survival at the individual implant level (relative risk was 1.39; p=0.11) or at the patient level (relative risk 0.98; p=0.94). While 0.18 mm greater marginal bone loss was found for implants placed in persons with osteoporosis (p=0.005), it was unclear if this had any clinical relevance as implant survival did not differ.8Wang X, Shaffer JR, Weyant RJ, Cuenco KT, DeSensi RS, Crout R, McNeil DW, Marazita ML. Genes and their effects on dental caries may differ between primary and permanent dentitions. Caries Res 2010;44:277-84. An earlier review examined the influence of several factors on the risk for failure of dental implants.6 Four of 51 studies evaluated the influence of osteoporosis on implant survival in 3,070 implants. A direct association was found for risk of implant failure in patients with osteoporosis, but did not reach statistically significance (RR=1.09; p=0.14). However, the researchers noted that the severity of osteoporosis was not addressed in the studies and that all were retrospective, ranging from 9 months to 10 years in length.6Nibali L, Di Iorio A, Tu YK, Vieira A. Host genetics role in the pathogenesis of periodontal disease and caries. J Clin Periodontol 2017;44:S18:52-78.
Further, a non-randomized multicenter study of implant outcomes in older women (59 to 83 years-of-age; mean age 67 years) with and without osteoporosis/osteopenia has recently been published.4Opal S, Garg S, Jain J, Walia I. Genetic factors affecting dental caries risk. Aust Dent J 2015;60:2-11. At one year after functional loading, implant survival and marginal bone loss were evaluated for 46 of 48 patients with screw-retained or bar overdenture implant-supported restorations. Implants placed in women with osteoporosis/osteopenia demonstrated comparable survival rates to implants placed in women without osteoporosis/osteopenia (on the implant level, 98.4% vs. 100% survival rate; p=0.43); on the person level, 94.7% vs. 100%; p=0.417). In addition, while marginal bone loss in patients with osteoporosis/osteopenia occurred mainly after functional loading and in patients without osteoporosis/osteopenia before functional loading, there were no statistically significant differences in absolute marginal bone loss at one year.4Opal S, Garg S, Jain J, Walia I. Genetic factors affecting dental caries risk. Aust Dent J 2015;60:2-11.
Implants placed in women with and without osteoporosis/osteopenia have demonstrated comparable survival rates.
A recent retrospective cross-sectional study examined peri-implant marginal bone loss (MBL) in women with and without osteoporosis (mean age 64 years).3Shuler CF. Inherited risks for susceptibility to dental caries. J Dent Educ 2001;65(10):1038-45. At one year, proximal bone loss was more pronounced adjacent to implants placed in women with osteoporosis. Mean mesial and distal MBL were -1.1 mm ±-1.3, and -1.2 mm ±1.3, respectively, vs. -0.6 ±1.2 mm and -0.5 mm ±1.3, respectively, in women with (n=18) and without (n=30) osteoporosis. (Figure 1) This difference was significant after adjusting for confounders, including smoking and treatment with bisphosphonates (BP). Study limitations included the short evaluation period of one year, and some but not all patients were treated with vitamin D or BP. Additionally, 7 patients were diagnosed with osteoporosis prior to, 4 at the time of, and 7 subsequent to implant placement, Osteoporosis was not considered a contraindication for implant placement in women with osteoporosis.3Shuler CF. Inherited risks for susceptibility to dental caries. J Dent Educ 2001;65(10):1038-45.
In a retrospective study of more than 4,000 patients with over 13,000 implants placed between 2004 and 2012, 81 patients had a history of osteoporosis (1.9%).7Lips A, Antunes LS, Pintor AVB, dos Santos DAB, Bachinski R, Küchler EC, Alves GG. Salivary protein polymorphisms and risk of dental caries: a systematic review. Braz Oral Res 2017;31:e41. The up-to-8-year survival rate was 94.4% for patients with osteoporosis, with no statistically significant difference in survival rate compared with healthy patients without osteoporosis (p=0.661). However, failure rates for patients with osteoporosis were higher in the maxilla than the mandible, and it was suggested that anatomical differences in bone microarchitecture might play a role.7Lips A, Antunes LS, Pintor AVB, dos Santos DAB, Bachinski R, Küchler EC, Alves GG. Salivary protein polymorphisms and risk of dental caries: a systematic review. Braz Oral Res 2017;31:e41. In another study with a mean follow-up of more than 5 years, 79 elderly patients with lowered BMD received implant-supported mandibular overdentures.9Corby PM, Bretz WA, Hart TC, Schork NJ, Wessel J, Lyons-Weiler J, Paster BJ. Heritability of oral microbial species in caries-active and caries-free twins. Twin Res Hum Genet 2007;10(6):821-8. The implant survival rate was 98.7%, and on examination of 63 available patients no association was found for BMD and the amount of MBL (p=0.466). It was concluded that osteoporosis was not a contraindication for implant therapy.9Corby PM, Bretz WA, Hart TC, Schork NJ, Wessel J, Lyons-Weiler J, Paster BJ. Heritability of oral microbial species in caries-active and caries-free twins. Twin Res Hum Genet 2007;10(6):821-8.

Figure 1. Mean marginal bone loss in women with and without osteoporosis3Shuler CF. Inherited risks for susceptibility to dental caries. J Dent Educ 2001;65(10):1038-45.



In a retrospective study, the up-to-8-year survival rate was 94.4% for patients with osteoporosis and similar to the rate for healthy patients without osteoporosis.

Other reviews and studies have also failed to find evidence for osteoporosis as an absolute or relative contraindication for implant placement, including a recent qualitative review in which the implant survival rate was similar for patients with and without osteoporosis.10Papapostolou A, Kroffke B, Tatakis DN, Nagaraja HN, Kumar PS. Contribution of host genotype to the composition of health-associated supragingival and subgingival microbiomes. J Clin Periodontol 2011;38:517-24.,11Gomez A, Espinoza JL, Harkins DM, Leong P, Saffery R, Bockmann M, Torralba M, Kuelbs C, Kodukula R, Inman J, Hughes T, Craig JM, Highlander SK, Jones MB, Dupont CL, Nelson KE. Host genetic control of the oral microbiome in health and disease. Cell Host Microbe 2017;22:269-78 e263.,12Shaffer JR, Wang X, McNeil DW, Weyant RJ, Crout R, Marazita ML. Genetic susceptibility to dental caries differs between the sexes: a family-based study. Caries Res 2015;49:133-40.,13Stahringer SS, Clemente JC, Corley RP, Hewitt J, Knights D, Walters WA, Knight R, Krauter KS. Nurture trumps nature in a longitudinal survey of salivary bacterial communities in twins from early adolescence to early adulthood. Genome Res 2012;22:2146-52. One study has also assessed peri-implantitis, finding no significant differences in the percentage of implants with peri-implantitis, evaluated for up to 10 years after insertion, for patients with and without osteoporosis.14Momeni SS, Whiddon J, Cheon K, Ghazal T, Moser SA, Childers NK. Genetic diversity and evidence for transmission of streptococcus mutans by DiversiLab rep-PCR. J Microbiol Methods 2016;128:108-17.

Implant stability

In one study, it was observed that MBL was significantly greater in the maxilla than the mandible for patients with osteoporosis, leading to the conclusion that achieving primary stability may differ for the two jaws.3Shuler CF. Inherited risks for susceptibility to dental caries. J Dent Educ 2001;65(10):1038-45. In a separate study, implant stability was assessed using resonance frequency analysis for 49 patients with and without osteoporosis.15Paglia L, Scaglioni S, Torchia V, De Cosmi V, Moretti M, Marzo G, Giuca MR. Familial and dietary risk factors in early childhood caries. Eur J Paediatr Dent 2016;17:93-9. While statistically significant differences were found for implant stability when comparing patients with osteoporosis to patients with a physiologically healthy BMD, implant osseointegration was achieved for all patient groups. Primary stability measured as the implant stability quotient (ISQ) was 63.3 ± 10.3, 65.3 ± 7.5 and 66.7 ± 8.7 ISQ, respectively, for patients with osteoporosis, osteopenia and without either condition (Figure 2). Following osseointegration, implant stability at the time of abutment placement measured 66.4 ± 9.5, 70.7 ± 7.8, and 72.2 ± 7.2 ISQ, respectively.15Paglia L, Scaglioni S, Torchia V, De Cosmi V, Moretti M, Marzo G, Giuca MR. Familial and dietary risk factors in early childhood caries. Eur J Paediatr Dent 2016;17:93-9.

Figure 2. Primary implant stability and stability at abutment placement (ISQ)

 



Implant surface morphology

Significantly less MBL has been observed to occur around rough-surface implants compared to machined (smooth surface) implants in patients with osteoporosis.3Shuler CF. Inherited risks for susceptibility to dental caries. J Dent Educ 2001;65(10):1038-45. Further, in a recent systematic review examining the impact of surface coatings on dental implants placed in osteoporotic bone in 6 laboratory studies, bone volume and bone-in-contact (BIC) were found in 5 of the 6 studies to be significantly greater for implants with osteoinductive and osteoproliferative coatings compared to non-coated implants.16Kong Y-Y, Zheng J-M, Zhang W-J, Jiang Q-Z, Yang X-C, Yu M, Zeng SuJ. The relationship between vitamin D receptor gene polymorphism and deciduous tooth decay in Chinese children. BMC Oral Health 2017;17:111. Laboratory studies also indicate that microrough-surface implants result in greater tissue maturation at 3 days and osseointegration at 14 days than is observed for machined surfaces under conditions of reduced BMD.17American Dental Association. Symposium on Early Childhood Caries in American Indian and Alaska Native Children, 2010.

Anti-resorptive therapy in patients with osteoporosis

The risk of implant failure and osteonecrosis of the jaw (ONJ) in patients with osteoporosis receiving anti-resorptive therapy, typically bisphosphonates (BP), is a further consideration.18Vieira AR, Marazita ML, Goldstein-McHenry T. Genome-wide scan finds suggestive caries loci. J Dent Res 2008;87(5):435-9. A prevalence of ≤0.1% was estimated for BP-induced ONJ for this patient population in one review.19Vieira AR, Modesto A, Marazita ML. Caries: review of human genetics research. Caries Res 2014;48:491-506. A more recent position paper reported an overall prevalence close to 0% (range 0.00038% to 0.1%) for patients receiving oral BP for <4 years, and up to 0.21% for longer-term use of oral BP.20Acton RT, Dasanayake AP, Harrison RA, Li Y, Roseman JM, Go RCP, Wiener H, Caufield PW. Association of MHC genes with levels of caries-inducing organisms and caries severity in African-American women. Human Immunol 1999;60:984-9. In another review, in most studies implant failure was not observed in patients with osteoporosis receiving BP therapy within the study timeframes.18Vieira AR, Marazita ML, Goldstein-McHenry T. Genome-wide scan finds suggestive caries loci. J Dent Res 2008;87(5):435-9.
In a systematic review with meta-analysis of 8 studies with more than 4,500 implants placed, insufficient evidence was found for any impact of BP on implant survival.21Bagherian A, Nematollahi H, Afshari JT, Moheghi N. Comparison of allele frequency for hla-dr and hla-dq between patients with ecc and caries-free children. J Indian Soc Pedod Prev Dent 2008;26:18-21. However, informed consent about the risk of long-term implant failure and low risk of BP-ONJ is advised. It is also suggested that, in consultation with the patient’s medical provider and depending on the patient’s condition and the risk versus benefit, that consideration be given to stopping BP therapy for 2 months prior to implant placement and until osseous healing has occurred, or changing the dose, or using a different drug.20Acton RT, Dasanayake AP, Harrison RA, Li Y, Roseman JM, Go RCP, Wiener H, Caufield PW. Association of MHC genes with levels of caries-inducing organisms and caries severity in African-American women. Human Immunol 1999;60:984-9.
In a systematic review with meta-analysis of 8 studies with more than 4,500 implants placed, insufficient evidence was found for any impact of BP on implant survival.

Conclusions

Osteoporosis is not a contraindication to implant treatment. As populations age, an increasing number of people will require dental implants to maintain oral function, and may present with or subsequently develop osteoporosis. Patients must be informed of the risks, including increased MBL around implants and implant failure.20Acton RT, Dasanayake AP, Harrison RA, Li Y, Roseman JM, Go RCP, Wiener H, Caufield PW. Association of MHC genes with levels of caries-inducing organisms and caries severity in African-American women. Human Immunol 1999;60:984-9. Patients should also be educated about the need for sound oral hygiene practices and regular dental care for on-going evaluation.19Vieira AR, Modesto A, Marazita ML. Caries: review of human genetics research. Caries Res 2014;48:491-506.,20Acton RT, Dasanayake AP, Harrison RA, Li Y, Roseman JM, Go RCP, Wiener H, Caufield PW. Association of MHC genes with levels of caries-inducing organisms and caries severity in African-American women. Human Immunol 1999;60:984-9. Lastly, there is a need for additional, well-designed, longer-duration and larger sample size studies to assess the impact of severity of osteoporosis on implant survival, as well as the effect of comorbidities such as smoking or diabetes mellitus, and the impact of BP therapy.6Nibali L, Di Iorio A, Tu YK, Vieira A. Host genetics role in the pathogenesis of periodontal disease and caries. J Clin Periodontol 2017;44:S18:52-78.,8Wang X, Shaffer JR, Weyant RJ, Cuenco KT, DeSensi RS, Crout R, McNeil DW, Marazita ML. Genes and their effects on dental caries may differ between primary and permanent dentitions. Caries Res 2010;44:277-84.10Papapostolou A, Kroffke B, Tatakis DN, Nagaraja HN, Kumar PS. Contribution of host genotype to the composition of health-associated supragingival and subgingival microbiomes. J Clin Periodontol 2011;38:517-24.,21Bagherian A, Nematollahi H, Afshari JT, Moheghi N. Comparison of allele frequency for hla-dr and hla-dq between patients with ecc and caries-free children. J Indian Soc Pedod Prev Dent 2008;26:18-21.

References

  • 1.Dominy SS, et al. Porphyromonas gingivalis in Alzheimer’s disease brains: Evidence for disease causation and treatment with small-molecule inhibitors. Sci Adv. 2019;5(1):eaau3333 https://www.ncbi.nlm.nih.gov/pubmed/30746447.
  • 2.Sadrameli M, et al. Linking mechanisms of periodontitis to Alzheimer’s disease. Curr Opin Neurol. 2020;33(2):230-8 https://www.ncbi.nlm.nih.gov/pubmed/32097126.
  • 3.Borsa L, et al. Analysis the link between periodontal diseases and Alzheimer’s disease: A systematic review. Int J Environ Res Public Health. 2021;18(17) https://www.ncbi.nlm.nih.gov/pubmed/34501899.
  • 4.Costa MJF, et al. Relationship of Porphyromonas gingivalis and Alzheimer’s disease: A systematic review of pre-clinical studies. Clin Oral Investig. 2021;25(3):797-806 https://www.ncbi.nlm.nih.gov/pubmed/33469718.
  • 5.Munoz Fernandez SS, Lima Ribeiro SM. Nutrition and Alzheimer disease. Clin Geriatr Med. 2018;34(4):677-97 https://www.ncbi.nlm.nih.gov/pubmed/30336995.
  • 6.Aquilani R, et al. Is the Brain Undernourished in Alzheimer’s Disease? Nutrients. 2022;14(9) https://www.ncbi.nlm.nih.gov/pubmed/35565839.
  • 7.Fukushima-Nakayama Y, et al. Reduced mastication impairs memory function. J Dent Res. 2017;96(9):1058-66 https://www.ncbi.nlm.nih.gov/pubmed/28621563.
  • 8.Kim HB, et al. Abeta accumulation in vmo contributes to masticatory dysfunction in 5XFAD Mice. J Dent Res. 2021;100(9):960-7 https://www.ncbi.nlm.nih.gov/pubmed/33719684.
  • 9.Miura H, et al. Relationship between cognitive function and mastication in elderly females. J Oral Rehabil. 2003;30(8):808-11 https://www.ncbi.nlm.nih.gov/pubmed/12880404.
  • 10.Lexomboon D, et al. Chewing ability and tooth loss: association with cognitive impairment in an elderly population study. J Am Geriatr Soc. 2012;60(10):1951-6 https://www.ncbi.nlm.nih.gov/pubmed/23035667.
  • 11.Elsig F, et al. Tooth loss, chewing efficiency and cognitive impairment in geriatric patients. Gerodontology. 2015;32(2):149-56 https://www.ncbi.nlm.nih.gov/pubmed/24128078.
  • 12.Kim EK, et al. Relationship between chewing ability and cognitive impairment in the rural elderly. Arch Gerontol Geriatr. 2017;70:209-13 https://www.ncbi.nlm.nih.gov/pubmed/28214402.
  • 13.Kim MS, et al. The association between mastication and mild cognitive impairment in Korean adults. Medicine (Baltimore). 2020;99(23):e20653 https://www.ncbi.nlm.nih.gov/pubmed/32502052.
  • 14.Cardoso MG, et al. Relationship between functional masticatory units and cognitive impairment in elderly persons. J Oral Rehabil. 2019;46(5):417-23 https://www.ncbi.nlm.nih.gov/pubmed/30614023.
  • 15.Popovac A, et al. Oral health status and nutritional habits as predictors for developing alzheimer’s disease. Med Princ Pract. 2021;30(5):448-54 https://www.ncbi.nlm.nih.gov/pubmed/34348313.
  • 16.Park T, et al. More teeth and posterior balanced occlusion are a key determinant for cognitive function in the elderly. Int J Environ Res Public Health. 2021;18(4) https://www.ncbi.nlm.nih.gov/pubmed/33669490.
  • 17.Lin CS, et al. Association between tooth loss and gray matter volume in cognitive impairment. Brain Imaging Behav. 2020;14(2):396-407 https://www.ncbi.nlm.nih.gov/pubmed/32170642.
  • 18.Kumar S, et al. Oral health status and treatment need in geriatric patients with different degrees of cognitive impairment and dementia: a cross-sectional study. J Family Med Prim Care. 2021;10(6):2171-6 https://www.ncbi.nlm.nih.gov/pubmed/34322409.
  • 19.Delwel S, et al. Chewing efficiency, global cognitive functioning, and dentition: A cross-sectional observational study in older people with mild cognitive impairment or mild to moderate dementia. Front Aging Neurosci. 2020;12:225 https://www.ncbi.nlm.nih.gov/pubmed/33033478.
  • 20.Da Silva JD, et al. Association between cognitive health and masticatory conditions: a descriptive study of the national database of the universal healthcare system in Japan. Aging (Albany NY). 2021;13(6):7943-52 https://www.ncbi.nlm.nih.gov/pubmed/33739304.
  • 21.Galindo-Moreno P, et al. The impact of tooth loss on cognitive function. Clin Oral Investig. 2022;26(4):3493-500 https://www.ncbi.nlm.nih.gov/pubmed/34881401.
  • 22.Stewart R, et al. Adverse oral health and cognitive decline: The health, aging and body composition study. J Am Geriatr Soc. 2013;61(2):177-84 https://www.ncbi.nlm.nih.gov/pubmed/23405916.
  • 23.Dintica CS, et al. The relation of poor mastication with cognition and dementia risk: A population-based longitudinal study. Aging (Albany NY). 2020;12(9):8536-48 https://www.ncbi.nlm.nih.gov/pubmed/32353829.
  • 24.Kim MS, Han DH. Does reduced chewing ability efficiency influence cognitive function? Results of a 10-year national cohort study. Medicine (Baltimore). 2022;101(25):e29270 https://www.ncbi.nlm.nih.gov/pubmed/35758356.
  • 25.Ko KA, et al. The Impact of Masticatory Function on Cognitive Impairment in Older Patients: A Population-Based Matched Case-Control Study. Yonsei Med J. 2022;63(8):783-9 https://www.ncbi.nlm.nih.gov/pubmed/35914761.
  • 26.Garre-Olmo J. [Epidemiology of Alzheimer’s disease and other dementias]. Rev Neurol. 2018;66(11):377-86 https://www.ncbi.nlm.nih.gov/pubmed/29790571.
  • 27.Stephan BCM, et al. Secular Trends in Dementia Prevalence and Incidence Worldwide: A Systematic Review. J Alzheimers Dis. 2018;66(2):653-80 https://www.ncbi.nlm.nih.gov/pubmed/30347617.
  • 28.Lopez OL, Kuller LH. Epidemiology of aging and associated cognitive disorders: Prevalence and incidence of Alzheimer’s disease and other dementias. Handb Clin Neurol. 2019;167:139-48 https://www.ncbi.nlm.nih.gov/pubmed/31753130.
  • 29.Ono Y, et al. Occlusion and brain function: mastication as a prevention of cognitive dysfunction. J Oral Rehabil. 2010;37(8):624-40 https://www.ncbi.nlm.nih.gov/pubmed/20236235.
  • 30.Kubo KY, et al. Masticatory function and cognitive function. Okajimas Folia Anat Jpn. 2010;87(3):135-40 https://www.ncbi.nlm.nih.gov/pubmed/21174943.
  • 31.Chen H, et al. Chewing Maintains Hippocampus-Dependent Cognitive Function. Int J Med Sci. 2015;12(6):502-9 https://www.ncbi.nlm.nih.gov/pubmed/26078711.
  • 32.Azuma K, et al. Association between Mastication, the Hippocampus, and the HPA Axis: A Comprehensive Review. Int J Mol Sci. 2017;18(8) https://www.ncbi.nlm.nih.gov/pubmed/28771175.
  • 33.Chuhuaicura P, et al. Mastication as a protective factor of the cognitive decline in adults: A qualitative systematic review. Int Dent J. 2019;69(5):334-40 https://www.ncbi.nlm.nih.gov/pubmed/31140598.
  • 34.Lopez-Chaichio L, et al. Oral health and healthy chewing for healthy cognitive ageing: A comprehensive narrative review. Gerodontology. 2021;38(2):126-35 https://www.ncbi.nlm.nih.gov/pubmed/33179281.
  • 35.Tada A, Miura H. Association between mastication and cognitive status: A systematic review. Arch Gerontol Geriatr. 2017;70:44-53 https://www.ncbi.nlm.nih.gov/pubmed/28042986.
  • 36.Ahmed SE, et al. Influence of Dental Prostheses on Cognitive Functioning in Elderly Population: A Systematic Review. J Pharm Bioallied Sci. 2021;13(Suppl 1):S788-S94 https://www.ncbi.nlm.nih.gov/pubmed/34447202.
  • 37.Tonsekar PP, et al. Periodontal disease, tooth loss and dementia: Is there a link? A systematic review. Gerodontology. 2017;34(2):151-63 https://www.ncbi.nlm.nih.gov/pubmed/28168759.
  • 38.Nangle MR, Manchery N. Can chronic oral inflammation and masticatory dysfunction contribute to cognitive impairment? Curr Opin Psychiatry. 2020;33(2):156-62 https://www.ncbi.nlm.nih.gov/pubmed/31895157.
  • 39.Nakamura T, et al. Oral dysfunctions and cognitive impairment/dementia. J Neurosci Res. 2021;99(2):518-28 https://www.ncbi.nlm.nih.gov/pubmed/33164225.
  • 40.Weijenberg RAF, et al. Mind your teeth-The relationship between mastication and cognition. Gerodontology. 2019;36(1):2-7 https://www.ncbi.nlm.nih.gov/pubmed/30480331.
  • 41.Asher S, et al. Periodontal health, cognitive decline, and dementia: A systematic review and meta-analysis of longitudinal studies. J Am Geriatr Soc. 2022;70(9):2695-709 https://www.ncbi.nlm.nih.gov/pubmed/36073186.
  • 42.Lin CS. Revisiting the link between cognitive decline and masticatory dysfunction. BMC Geriatr. 2018;18(1):5 https://www.ncbi.nlm.nih.gov/pubmed/29304748.
  • 43.Wu YT, et al. The changing prevalence and incidence of dementia over time – current evidence. Nat Rev Neurol. 2017;13(6):327-39 https://www.ncbi.nlm.nih.gov/pubmed/28497805.
  • 44.National Psoriasis Foundation. Soriatane (Acitretin). https://www.psoriasis.org/soriatane-acitretin/.
  • 45.National Psoriasis Foundation. Current Biologics on the Market. https://www.psoriasis.org/current-biologics-on-the-market/.
  • 46.Dalmády S, Kemény L, Antal M, Gyulai R. Periodontitis: a newly identified comorbidity in psoriasis and psoriatic arthritis. Expert Rev Clin Immunol 2020;16(1):101-8. doi: 10.1080/1744666X.2019.1700113.
  • 47.Mickenautsch S, Yengopal V. Effect of xylitol versus sorbitol: a quantitative systematic review of clinical trials. Int Dent J 2012;62(4):175-88.
  • 48.Rethman MP, Beltrán-Aguilar ED, Billings RJ, Burne RA, Clark M, Donly KJ, Hujoel PP, Katz BP, Milgrom P, Sohn W, Stamm JW, Watson G, Wolff M, Wright T, Zero D, Aravamudhan K, Frantsve-Hawley J, Meyer DM; for the American Dental Association Council on Scientific Affairs Expert Panel on Nonfluoride Caries-Preventive Agents. Nonfluoride caries-preventive agents. Executive summary of evidence-based clinical recommendations. J Am Dent Assoc 2011;142(9):1065-71.
  • 49.Milgrom P, Söderling EM, Nelson S, Chi DL, Nakai Y. Clinical evidence for polyol efficacy. Adv Dent Res 2012; 24(2):112-6.
Login to access